Skip to main content
logo
Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · Real-Time Price · USD
2.420
+0.030 (1.26%)
Aug 6, 2026, 4:00 PM EDT - Market closed

Atossa Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-39.6-37.14-27.62-31.38-27.69-20.52
Net Income
-37.64-34.77-25.5-30.09-26.96-20.61
Earnings Per Share
-4.55-4.04-3.04-3.60-3.15-2.70
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
31.7241.371.0888.46110.89136.38
Total Debt
000000
Net Cash (Debt)
31.7241.371.0888.46110.89136.38
Net Cash Growth
-51.29%-41.90%-19.64%-20.23%-18.69%244.94%
Net Cash Per Share
3.684.808.4710.5213.1417.49

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-33.38-29.76-21.03-20.94-20.76-16.47
Capital Expenditures
-0.01-0.02-0.02-0.01-0.03-0.01
Free Cash Flow
-33.4-29.79-21.05-20.96-20.79-16.48
Free Cash Flow Growth
------

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-181.67181.67181.67181.67181.67